Tag: Biotech
BioVoice eMagazine July & August 2024 | Issue 4 | Volume...
The Cover Story tracks how biosupplier industry is powering India’s smart biotech labs and profiles the leading 20 companies. Read interview of Amit Patjoshi, CEO of Palladium India. Expert Insights by Dr Avinash Phadke, President & Mentor, Agilus Diagnostics, Harsh Vardhan Bhagchandka, President, IPL Biologicals and A P Sinha, Director, Farlense Group.
“All our services are backed up by qualified & experienced technical...
Ramesh Raju, Head – Validations Services, Merck Life Science India explains the latest scenario in validation services within biopharma industry, his company’s offerings, challenges and technological advancements
Bharat Biotech adds ICMR as co-owner of Covid-19 vaccine patent
These actions are in accordance with the Memorandum of Understanding (MoU) signed between ICMR-NIV Pune and BBIL for joint development of COVID-19 vaccine in April 2020
Private biotech rebounds with 46% growth in venture funding during Q1...
Private biotech venture financing saw a downturn during 2022 and 2023, influenced by macroeconomic challenges such as high interest rates and inflation
CIPLA EU to invest an additional EUR 3 million in Ethris
This additional investment through a convertible loan will accelerate Cipla’s participation in the mRNA space
Syngenta opens rights to genome-editing & breeding technologies to boost agricultural...
These rights are accessible through its innovation collaboration platform Shoots by Syngenta
Borosil Scientific debuts on stock exchange
This significant milestone marks a new chapter in the company's legacy of innovation and excellence in the scientific and industrial sectors
Enzene launches discovery services division at BIO 2024
CDMO provides end-to-end drug discovery, development and commercialization services with sites in both the USA and Asia
Merck KGaA announces €300 million investment in South Korea for new...
The new €300 million Bioprocessing Production Center in Daejeon will manufacture vaccines, cell and gene therapies, and protein-based therapies, creating 300 new jobs
Annapurna Das appointed as new General Manager for Takeda’s India operations
With over 20 years of experience, Das to lead initiatives in enhancing patient access to innovative medicines and strengthening collaborations in the Indian healthcare sector






























































